Inhibitors of cathepsin G: a patent review (2005 to present)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.12, 2013-12, pp. : 1611-1624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of cathepsin K: a patent review (2004 – 2010)

By Wijkmans Jac Gossen Jan

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1611-1629

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors: a patent review (2008 – present)

By Pohanka Miroslav

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 871-886

Informa Healthcare

Access to resources Recommend Favorite

Hedgehog pathway inhibitors: a patent review (2009 – present)

By Hadden Matthew Kyle

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors: a patent review (2010 – present)

By Sobhia Masilamani Elizabeth Grewal Baljinder K Paul Matam Losery Stanly Patel Jigneshkumar Kaur Amandeep Haokip Thongtinlal Kokkula Alekhya

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1451-1468

Informa Healthcare

Access to resources Recommend Favorite

Kinesin spindle protein inhibitors in cancer: a patent review (2008 – present)

By Jiang Cheng You Qidong

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite